FINWIRES · TerminalLIVE
FINWIRES

Update: CECO Environmental Shares Rise After Updating 2026 Outlook Following Thermon Group Acquisition

By

(Updates with the latest stock movement in the first paragraph and headline.)

CECO Environmental (CECO) shares were up roughly 14% in Tuesday afternoon trading after the company said it now expects 2026 revenue of about $1.28 billion to $1.38 billion, after closing its acquisition of Thermon Group Holdings (THR) on June 1.

The company previously projected 2026 revenue of $940 million to $1 billion. Analysts polled by FactSet expect $968.3 million.

The updated outlook, which includes $195 million to $225 million in adjusted EBITDA, reflects seven months of contribution from Thermon, CECO said.

The initial integration phase of Thermon into CECO is on track and the company continues to expect at least $40 million in cost synergies from the transaction, according to CECO CEO Todd Gleason.

Price: $91.55, Change: $+11.02, Percent Change: +13.68%

Related Articles

Wire

Mission Produce Fiscal Q2 Adjusted Earnings, Revenue Fall; Shares Drop After Hours

Mission Produce (AVO) reported fiscal Q2 non-GAAP net income late Monday of $0.01 per diluted share, down from $0.12 a year earlier.Three analysts polled by FactSet expected $0.05.Revenue in the three months ended April 30 fell to $290.9 million from $380.3 million a year earlier.Three analysts expected $256.3 million.The board approved a stock repurchase program of up to $100 million over the next 36 months.The company's shares fell 5.9% in after-hours trading.

$AVO
Wire

Mama's Creations Fiscal Q1 Earnings, Revenue Rise

Mama's Creations (MAMA) reported fiscal Q1 earnings late Monday of $0.05 per diluted share, up from $0.03 a year earlier.Analysts polled by FactSet expected $0.03.Revenue in the three months ended April 30 rose to $52.8 million from $35.3 million a year earlier.Analysts expected $51.6 million.The company's shares fell 2.6% in after-hours trading.

$MAMA
Wire

Tango Therapeutics Launches $500 Million Stock Offering

Tango Therapeutics (TNGX) said Monday it is launching $500 million underwritten public offering of common stock.All shares are offered by the company, according to a statement.Tango said it will grant underwriters a 30-day option to purchase up to an additional $75 million of shares.

$TNGX